Which of the K/DOQI guidelines for bone disease in dialysis patients should be changed?

被引：2
作者：
Gal-Moscovici, Anca
Sprague, Stuart M.
Hutchison, Alastair J.
Shah, Nirav
Piraino, Beth
Cunningham, John
机构：
[1] Northwestern Univ, Feinberg Sch Med, Evanston NW Healthcare, Dept Med,Div Nephrol & Hypertens, Evanston, IL 60201 USA
[2] Hebrew Univ Jerusalem, Hadassah Hosp Med Ctr, Jerusalem, Israel
[3] Manchester Inst Nephrol & Transplantat, Manchester M13 9WL, Lancs, England
[4] Univ Pittsburgh, Dept Med, Renal Electrolyte Div, Pittsburgh, PA USA
[5] UCL Royal Free & Univ Coll Med Sch, Dept Nephrol, London NW3 2PF, England
来源：
SEMINARS IN DIALYSIS | 2007年 / 20卷 / 01期
关键词：
D O I：
10.1111/j.1525-139X.2007.00234.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：24 / 32
页数：9
相关论文
共 69 条
[1]   The role of daily dialysis in the control of hyperphosphatemia [J].
Achinger, SG ;
Ayus, JC .
KIDNEY INTERNATIONAL, 2005, 67 :S28-S32
[2]   Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observation [J].
Avram, MM ;
Mittman, N ;
Myint, MM ;
Fein, P .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (06) :1351-1357
[3]   Effects of vitamin D and calcium supplementation on falls:: A randomized controlled trial [J].
Bischoff, HA ;
Stähelin, HB ;
Dick, W ;
Akos, R ;
Knecht, M ;
Salis, C ;
Nebiker, M ;
Theiler, R ;
Pfeifer, M ;
Begerow, B ;
Lew, RA ;
Conzelmann, M .
JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (02) :343-351
[4]   Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease [J].
Blacher, J ;
Guerin, AP ;
Pannier, B ;
Marchais, SJ ;
London, GM .
HYPERTENSION, 2001, 38 (04) :938-942
[5]   Calcium phosphate metabolism and cardiovascular disease in patients with chronic kidney disease [J].
Block, G ;
Port, FK .
SEMINARS IN DIALYSIS, 2003, 16 (02) :140-147
[6]   Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis [J].
Block, GA ;
Martin, KJ ;
de Francisco, ALM ;
Turner, SA ;
Avram, MM ;
Suranyi, MG ;
Hercz, G ;
Cunningham, J ;
Abu-Alfa, AK ;
Messa, P ;
Coyne, DW ;
Locatelli, F ;
Cohen, RM ;
Evenepoel, P ;
Moe, SM ;
Fournier, A ;
Braun, J ;
McCary, LC ;
Zani, VJ ;
Olson, KA ;
Drüeke, TB ;
Goodman, WG .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1516-1525
[7]   Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management [J].
Block, GA ;
Port, FK .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (06) :1226-1237
[8]   Mineral metabolism, mortality, and morbidity in maintenance hemodialysis [J].
Block, GA ;
Klassen, PS ;
Lazarus, JM ;
Ofsthun, N ;
Lowrie, EG ;
Chertow, GM .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (08) :2208-2218
[9]   Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study [J].
Block, GA ;
Hulbert-Shearon, TE ;
Levin, NW ;
Port, FK .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (04) :607-617
[10]   Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis [J].
Block, GA ;
Spiegel, DM ;
Ehrlich, J ;
Mehta, R ;
Lindbergh, J ;
Dreisbach, A ;
Raggi, P .
KIDNEY INTERNATIONAL, 2005, 68 (04) :1815-1824
1234567